APA (7th ed.) Citation

Wang, W., Liu, H., Wen, Y., Zhang, Y., & Ma, X. An integrated approach based on FDA adverse event reporting system, network pharmacology, molecular docking, and molecular dynamics simulation analysis to study the cardiac adverse reactions and mechanism of action of osimertinib. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Wang, Wenjuan, Hong Liu, Yongqing Wen, Yanhua Zhang, and Xu Ma. An Integrated Approach Based on FDA Adverse Event Reporting System, Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation Analysis to Study the Cardiac Adverse Reactions and Mechanism of Action of Osimertinib. Frontiers Media S.A.

MLA (9th ed.) Citation

Wang, Wenjuan, et al. An Integrated Approach Based on FDA Adverse Event Reporting System, Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation Analysis to Study the Cardiac Adverse Reactions and Mechanism of Action of Osimertinib. Frontiers Media S.A.